Recommendations for Successful Training on Methods of Delivery of Biologics for Cardiac Regeneration A Report of the International Society for Cardiovascular Translational Research

Authors :: Nabil, Dib
Philippe, Menasche
Jozef J, Bartunek
Andreas M, Zeiher
Andre, Terzic
Nicolas A, Chronos
Timothy D, Henry
Nicholas S, Peters
Francisco, Fernández-Avilés
Magdi, Yacoub
Timothy A, Sanborn
Anthony, Demaria
Richard A, Schatz
Doris A, Taylor
Shmuel, Fuchs
Silviu, Itescu
Leslie W, Miller
Jonathan H, Dinsmore
George D, Dangas
Jeffrey J, Popma
Jennifer L, Hall
David R, Holmes
Source :: JACC: Cardiovascular Interventions. (3):265-275
Publisher :: American College of Cardiology Foundation. Published by Elsevier Inc.
Abstract: The field of myocardial regeneration (angiogenesis and myogenesis) might prove to play an important role in the future management of cardiovascular disease. Stem cells are currently undergoing testing in Phase I and Phase II clinical trials. Methods of delivery will affect the outcome of such therapies, perhaps significantly. This document provides suggested guidance in 4 methods of delivery: endocardial, intracoronary, coronary sinus, and epicardial.

Full Text Access

Tools